,,

Salik Abdullah1, Ratul Chakraborty2, Pratiksha Somnath Kumkar3

  • 1Department of Pharmaceutical Chemistry, Bharat Technology under Maulana Abul Kalam Azad University of Technology, West Bengal, Banitabla, Uluberia, Howrah-711316, West Bengal, India.

概括

针对非小细胞肺癌 (NSCLC) 的个性化药物正在进步,这是由于基因发现. 基于分子分析的向疗法正在改善患者的生存率和治疗策略.